Title:LncRNA-mediated Modulation of Endothelial Cells: Novel Progress
in the Pathogenesis of Coronary Atherosclerotic Disease
Volume: 31
Issue: 10
Author(s): Shao Ouyang, Zhi-Xiang Zhou, Hui-Ting Liu, Zhong Ren, Huan Liu, Nian-Hua Deng, Kai-Jiang Tian, Kun Zhou, Hai-lin Xie and Zhi-Sheng Jiang*
Affiliation:
- Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease
Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang
421001, China
Keywords:
Long noncoding RNAs, endothelial cells, coronary atherosclerotic heart disease, diagnosis, drug therapy, smooth muscle cell.
Abstract: Coronary atherosclerotic disease (CAD) is a common cardiovascular disease
and an important cause of death. Moreover, endothelial cells (ECs) injury is an early
pathophysiological feature of CAD, and long noncoding RNAs (lncRNAs) can modulate
gene expression. Recent studies have shown that lncRNAs are involved in the pathogenesis
of CAD, especially by regulating ECs. In this review, we summarize the novel
progress of lncRNA-modulated ECs in the pathogenesis of CAD, including ECs proliferation,
migration, adhesion, angiogenesis, inflammation, apoptosis, autophagy, and pyroptosis.
Thus, as lncRNAs regulate ECs in CAD, lncRNAs will provide ideal and novel targets
for the diagnosis and drug therapy of CAD.